Medicines Design - Eggleston Flashcards

1
Q

What is the peptide and protein therapeutics “SWOT” analysis?

A

S = Strengths

W = Weaknesses

O = Opportunities

T = Threats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which type of HPLC is best for peptides?

A

Reverse phase HPLC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many AA are in each of the peptide chains in insulin?

A

Chain A = 21

Chain B = 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When would peptide mapping be done?

A

To see the difference between large peptides when there is only a 1/2 AA difference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does DPP4 inhibit GLP-1?

A

Cleaves off dipeptide units Xaa-Ala or Xaa-Pro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Liraglutide?

A

97% similar to GLP-1 –> so less immunogenicity than exenatide

Once daily doing (compared to exenatides 2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What type of protease is DDP4?

A

Serine Protease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why are non-covalent DDP-4 inhibitors better than regular ones?

A

As they have greater selectivity for DDP-4 –> When compaered to those than covalently bind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are SGLT2 molecules based off of?

A

Phlorizin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly